Announcements Trials
Browse Landscape

Phase

Phase 1 3

Status

Completed 3

Sponsor Class

INDUSTRY 4OTHER 3

Study Type

Interventional 3

Sponsor

Conditions

Breast Neoplasms 304Carcinoma, Non-Small-Cell Lung 182Ovarian Neoplasms 154Lung Neoplasms 92Esophageal Neoplasms 75Triple Negative Breast Neoplasms 71Stomach Neoplasms 71Fallopian Tube Neoplasms 68Squamous Cell Carcinoma of Head and Neck 51Esophageal Squamous Cell Carcinoma 50Neoplasm Metastasis 48Neoplasms 45Endometrial Neoplasms 42Head and Neck Neoplasms 41Carcinoma, Ovarian Epithelial 41Uterine Cervical Neoplasms 37Recurrence 26Carcinoma, Squamous Cell 23Adenocarcinoma Of Esophagus 22Urinary Bladder Neoplasms 19Melanoma 19Inflammatory Breast Neoplasms 19Prostatic Neoplasms 18Adenocarcinoma of Lung 17Carcinoma 15Breast Neoplasms, Male 15Unspecified Adult Solid Tumor, Protocol Specific 14Testicular Neoplasms 13Small Cell Lung Carcinoma 12Peritoneal Neoplasms 12

Interventions

Surveys and Questionnaires 7Standard of Care 5Sirolimus 5Bevacizumab 5temsirolimus 4Interviews as Topic 4Paclitaxel 3olaparib 2Vorinostat 2Olanzapine 2Magnetic Resonance Spectroscopy 2Gemcitabine 2Everolimus 2Erlotinib Hydrochloride 2Dasatinib 2Cetuximab 2zaleplon 1vistusertib 1tilsotolimod 1pazopanib 1olanzapine-fluoxetine combination 1nimotuzumab 1liposomal doxorubicin 1capivasertib 1apatinib 1Videotape Recording 1Vemurafenib 1Valproic Acid 1Trastuzumab 1Topotecan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Advanced Cancer × Paclitaxel × Clear all
NCT02193633 2024-09-26

TAX-TORC

Royal Marsden NHS Foundation Trust

Phase 1 Completed
90 enrolled

Advanced Cancer

NCT01113476 2022-09-02

Nab-paclitaxel, Gemcitabine, and Bevacizumab in Advanced Malignancies

M.D. Anderson Cancer Center

Phase 1 Completed
176 enrolled

Advanced Cancer

NCT00508326 2012-07-30

Paclitaxel Administered by HAI to Patients With Advanced Cancer and Dominant Liver Involvement

M.D. Anderson Cancer Center

Phase 1 Completed
27 enrolled

Advanced Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡